<DOC>
	<DOCNO>NCT00002975</DOCNO>
	<brief_summary>RATIONALE : Photodynamic therapy use light drug make cancer cell sensitive light kill tumor cell . Photodynamic therapy use aminolevulinic acid may effective treat patient skin cancer . PURPOSE : This randomized phase II trial study well photodynamic therapy include aminolevulinic acid work treat patient skin cancer .</brief_summary>
	<brief_title>Photodynamic Therapy Treating Patients With Skin Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine efficacy aminolevulinic acid laser irradiation patient superficial nodular epidermally derive lesion . OUTLINE : This randomize study . Patients stratify accord lesion type ( superficial basal cell carcinoma [ BCC ] v nodular BCC v superficial squamous cell carcinoma v actinic keratoses ) . Individual lesion patient within stratum randomize receive either 4-5 18-24 hour application aminolevulinic acid ( ALA ) . ALA topically apply cream mixture occlusive dressing place lesion . After randomized duration ALA application expire , dress remove dye laser use treat lesion . Patients follow 2-5 year treatment . PROJECTED ACCRUAL : Up 200 patient could accrue , assume 1 lesion per patient . 50 lesion require stratified group .</detailed_description>
	<mesh_term>Skin Neoplasms</mesh_term>
	<mesh_term>Precancerous Conditions</mesh_term>
	<mesh_term>Aminolevulinic Acid</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis 1 following : Actinic keratoses Histologically prove superficial nodular basal cell carcinoma ( BCC ) , squamous cell carcinoma situ ( Bowen 's disease ) , microinvasive squamous cell carcinoma No nodular BCC great 4 mm thick surgically remove No carcinoma uncertain margin require Moh 's surgery PATIENT CHARACTERISTICS : Age : Not specify Performance status : Not specify Life expectancy : Not specify Hematopoietic : Not specify Hepatic : Not specify Renal : Not specify Other : No known photosensitivity disease No porphyria hypersensitivity porphyrins PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : Not specify Endocrine therapy : Not specify Radiotherapy : Not specify Surgery : Not specify Other : No prior treatment systemic photosensitizer would cause residual cutaneous photosensitivity study participation</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>basal cell carcinoma skin</keyword>
	<keyword>squamous cell carcinoma skin</keyword>
	<keyword>actinic keratosis</keyword>
</DOC>